ECONOMIC BURDEN OF HEADACHE: DIRECT AND INDERECT CJST OF TREATING HEADACHE


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The above analysis of the literature showed that the direct cost of treating one patient with headache (H) priced at 3,600 rubles/year in Russia., while abroad, the figure ranges from 128 to 2250 € in Europe, from 529 up to $ 8243 in the US. Most of the funds spent on the purchase of medicines. In the US, 1 visit to the doctor about H priced at $263-363. In the Russian Federation of the cost of a single visit to a neurologist it varies from 500 rubles up to 1379 rubles in the budgetary organizations in the non-budgetary organizations tariff for medical services of a neurologist is much higher. In Russia, the loss of working days due to the H up to 8 days/year per 1 patient, and the loss of days of homework to 14. Abroad, the loss of days of work in manufacturing rated as 4-6.8 days per year, 4.2 days of work on home. The most expensive nosology in Russia and abroad is a migraine. Thus, the direct and indirect costs for treatment H is a significant economic burden on the health, industry and the state as a whole.

Толық мәтін

Рұқсат жабық

Авторлар туралы

A. Kondratev

FSBHCI Clinical Hospital №51 of the Federal Medical-Biological Agency of Russia

Email: kondrate-aleksej@yandex.ru
PhD, Neurosurgeon of Traumatology Department Zheleznogorsk

I. Artyukhov

SBE HPE «Krasnoyarsk State Medical University professor V.F. Voyno-Yasenetsky» tof RMH

Krasnoyarsk

A. Shulmin

SBE HPE «Krasnoyarsk State Medical University professor V.F. Voyno-Yasenetsky» tof RMH

Krasnoyarsk

N. Shnayder

FSBHCI Clinical Hospital №51 of the Federal Medical-Biological Agency of Russia; SBE HPE «Krasnoyarsk State Medical University professor V.F. Voyno-Yasenetsky» tof RMH

Zheleznogorsk; Krasnoyarsk

Әдебиет тізімі

  1. Кондратьев А.В, Шнайдер Н.А, Шульмин А.В. Эпидемиология головных болей. Современные проблемы науки и образования. 2015;6:http://www.science-education.ru
  2. Кондратьев А.В., Шнайдер Н.А., Шульмин А.В. и др. Предикторы первичной головной боли. Проблемы женского здоровья. 2016; 1:32-44.
  3. Ayzenberg I., Katsarava Z., Sborowski A., Chernysh M., Osipova V., Tabeeva G., Steiner T.J. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur. J. Neurol. 2014;21(5):758-65.
  4. Фокин И.В. Головная боль: основы организации медицинской помощи. М., 2008. 165 с.
  5. Berra E., Sances G., De Icco R., Avenali M., Berlangieri M., De Paoli I., Bolla M., Allena M., Ghiotto N., Guaschino E., Cristina S., Tassorelli C., Sandrini G., Nappi G. Cost of Chronic and Episodic Migraine. A pilot study from a tertiary headache centre in northern Italy. J. Headache Pain. 2015;16:532.
  6. Jordan Y.J., Lightfoote J.B., Jordan J.E. Computed tomography imaging in the management of headache in the emergency department: cost efficacy and policy implications. J. Natl. Med. Assoc. 2009;101(4):331-35.
  7. Schabert E., Crow W.T. Impact of osteopathic manipulative treatment on cost of care for patients with migraine headache: a retrospective review of patient records. J. Am. Osteopath. Assoc. 2009;109(8):403-7.
  8. Messali A., Sanderson J.C., Blumenfeld A.M., Goadsby P.J., Buse D.C., Varon S.F., Stokes M., Lipton R.B. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey. Headache. 2016;56(2):306-22.
  9. Osterhaus J.T., Gutterman D.L., Plachetka J.R. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2(1):67-76.
  10. Von Seggern R.L., Adelman J.U. Cost considerations in headache treatment. Part 2: Acute migraine treatment. Headache. 1996;36(8):493-502.
  11. Pradalier A., Auray J.P, Hasnaoui A., Alzahouri K., Dartigues J.F, Duru G., Henry P., Lantéri-Minet M., Lucas C., Chazot G., Gaudin A.F. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study Pharmacoeconomics. 2004;22(15):985-99.
  12. Evers S. Relevance of headache for population medicine. Health care, costs, working loss. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(8):946-51.
  13. Jürgens T.P, May A. Chronic cluster headache: how much does treatment cost? Schmerz. 2010;24(3):221-25.
  14. Gaul C., Finken J., Biermann J., Mostardt S., Diener H.C., Müller O., Wasem J., Neumann A. Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia. 2011;31(16):1664-72.
  15. Luo N., Fang Y., Tan F., Zhang Q., Zou D., Cao X., Xu X., Bai H., Ou J., Wu H., Chen Z., Zhou Y., Wan S., Hong Y., Wang J., Ding M., Zhang A., Zhu D., Dun J. Prevalence and burden of headache disorders: a comparative regional study in China. Headache. 2010;10:123-27.
  16. Luo N., Qi W., Tong W., Tan F., Zhang Q., He J., Zou D., Cao X., Xu X., Bai H., Ou J., Wu H., Chen Z., Zhou Y., Wan S., Hong Y., Wang J., Ding M., Zhang A., Zhu D., Fang Y. Prevalence and burden of headache disorders in two neighboring provinces of China. J. Clin. Neurosci. 2014;21(10):1750-54.
  17. Lampl C., Steiner T.J., Mueller T., Mirvelashvili E., Djibuti M., Kukava M., Dzagnidze A., Jensen R., Stovner L.J., Katsarava Z.; Global Campaign against Headache; International Headache Society Russian Linguistic Special Interest Group. Global Campaign against Headache; International Headache Society Russian Linguistic Special Interest Group. Will (or can) people pay for headache care in a poor country? J. Headache Pain. 2012;13(1):67-74.
  18. Фокин И.В. Оптимизация медико-экономической помощи больным мигренью на основе клинико-экономического анализа и оценки качества жизни. Дисс. докт. мед. наук. М., 2008.
  19. Ayzenberg I., Katsarava Z., Sborowski A., Obermann M., Chernysh M., Osipova V., Tabeeva G., Steiner T.J. Headache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden attributable to headache disorders. J. Headache Pain. 2015;20:15-7.
  20. Schwartz B.S., Stewart W.F., Lipton R.B. Lost workdays and decreased work effectiveness associated with headache in the workplace. J. Occup. Environ. Med. 1997;39(4):320-27.
  21. Rozen T.D., Fishman R.S. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache. 2012; 52(1):99-113.
  22. Olesen J., Lekander I., Andlin-Sobocki P., Jönsson B. Funding of headache research in Europe. Cephalalgia. 2007;27(9):995-99.
  23. Linde M., Gustavsson A., Stovner L.J., Steiner T.J., Barr J., Katsarava Z., Lainez J.M., Lampl C., Lantéri-Minet M., Rastenyte D., Ruizdela Torre E., Tassorelli C., Andrée C. The cost of headache disorders in Europe: the Eurolight project. Eur. J. Neurol. 2012;19(5):703-11.
  24. Головные боли. Информационный бюллетень Всемирной организации здравоохранения №277, октябрь 2012 г. ftp://www.who. int/mediacentre/factsheets/fs277/ru
  25. Jensen R., Rasmussen B.K. Burden of headache. Expert Rev. Pharmacoecon Outcomes Res. 2004;4(3):353-59.
  26. Vinding G.R.,Zeeberg P, Lyngberg A., Nielsen R.T., Jensen R. The burden of headache in a patient population from a specialized headache centre. Cephalalgia. 2007;27(3):263-70.
  27. Raak R., Raak A. Work attendance despite headache and its economic impact: a comparison between two workplaces. Headache. 2003;43(10):1097-101.
  28. Sokolovic E., Riederer F., Szucs T., Agosti R., Sśndor P.S. Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact. J. Headache Pain. 2013;26(14):29.
  29. Gérardy P.Y., Fumal A., Schoenen J. Epidemiology and economic repercussion of headache: an inquiery among the administrative and technical personnel of the Liège University. Rev. Med. Liege. 2008;63(5):310-14.
  30. Vincent M., Rodrigues Ade J., De Oliveira G.V., De Souza K.F., Doi L.M., Rocha M.B., Saporta M.A., Orleans R.B., Kotecki R., Estrela V.V., De Medeiros V.A., Borges W.l. Prevalence and indirect costs of headache in a Brazilian Company. Arq. Neuropsiquiatr. 1998;56(4):734-43.
  31. Selekler H.M., Gökmen G., Alvur T.M., Steiner T.J. Productivity losses attributable to headache, and their attempted recovery, in a heavy-manufacturing workforce in Turkey: implications for employers and politicians. J. Headache Pain. 2015;16:96.
  32. Rao G.N., Kulkarni G.B., Gururaj G., Stovner L.J., Steiner T.J. The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State. J. Headache Pain. 2015;16:94.
  33. Mbewe E., Zairemthiama P., Paul R., Birbeck G.L., Steiner T.J. The burden of primary headache disorders in Zambia: national estimates from a population-based door-to-door survey. J. Headache Pain. 2015;16:513.
  34. Manandhar K., Risal A., Linde M., Steiner T.J. The burden of headache disorders in Nepal: estimates from a population-based survey. J. Headache Pain. 2015;17(1):3.
  35. Leonardi M., Steiner T.J., Scher A.T., Lipton R.B. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (lCF). J. Headache Pain. 2005;6(6):429-40.
  36. Schwedt T.J., Shapiro R.E. Funding of research on headache disorders by the National lnstitutes of Health. Headache. 2009;49(2):162-69.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2016

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>